SCHEMBL21389092

SCHEMBL21389092

CCCC(NS(C)(=O)=O)C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.35
CA2 P00918 6/20 0.35
SIRT2 Q8IXJ6 2/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
HDAC6 Q9UBN7 3/20 0.34
HDAC9 Q9UKV0 3/20 0.34
HDAC5 Q9UQL6 3/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC10 Q969S8 2/20 0.34
HDAC11 Q96DB2 2/20 0.34
SCN9A Q15858 1/20 0.33
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21389077 1.00 CA1 (0.35) CA1CA2SIRT2HDAC7HDAC8
SCHEMBL12069014 0.83 SCN9A (0.34) CA1CA2SIRT2SCN9ACA12
SCHEMBL1724563 0.83 SCN9A (0.34) CA1CA2SIRT2SCN9ACA12
SCHEMBL12071190 0.83 SCN9A (0.34) CA1CA2SIRT2SCN9ACA12
SCHEMBL7416802 0.82 HDAC1 (0.43) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL7416795 0.82 HDAC1 (0.43) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL16371366 0.81 CA1 (0.33) CA1CA2HDAC7HDAC8HDAC6
Hydrochloric Acid SCHEMBL32662559 0.80 HDAC1 (0.41) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL3977175 0.79 ITGB3 (0.43) CA1CA2SIRT2CA12CA9
SCHEMBL7247656 0.79 CA12 (0.42) CA1CA2CA12CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292149-A1 ARYL SUBSTITUTED INDOLES AND THE USE THEREOF PURDUE PHARMA LP (US) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292149-A1 ARYL SUBSTITUTED INDOLES AND THE USE THEREOF TRPC5, TRPV5, TRPV1 CA1 1362/4885CA2 382/4885SIRT2 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.